Department of Dermatology, College of Medicine, Chung-Ang University, Seoul, Korea.
Department of Medicine, Graduate School, Chung-Ang University, Seoul, Korea.
J Cosmet Dermatol. 2019 Aug;18(4):1002-1008. doi: 10.1111/jocd.12950. Epub 2019 Apr 15.
Numerous fillers are increasingly used for augmentation of volume loss and relaxation of facial wrinkles. Collagen stimulators are the latest next-generation dermal fillers that can induce neocollagenesis. To investigate biophysical characteristics, safety, and efficacy of newly developed polydioxanone (PDO) filler in comparison with poly-l lactic acid (PLLA) and polycaprolactone (PCL) fillers.
In vitro assay, morphology of particles, and rheological property of fillers were measured. A total of 24 female hairless mice (SKH1-Hr ) were randomly divided into three groups and injected with PDO, PLLA, or PCL fillers. Durability of fillers was assessed at 0, 3 days, and 1, 4, 8, 12 weeks after injection using folliscope and PRIMOS. To determine biocompatibility and neocollagenesis, histologic evaluation was performed at 1, 4, 8, and 12 weeks after injection. Efficacy was also evaluated based on skin surface roughness changes using PRIMOS in a hairless mouse photoaging model.
In the particle morphology test, PDO microspheres had an irregular surface and were spherical and uniformly sized. PDO filler demonstrated similar neocollagenesis and inflammatory response to other collagen stimulators. PDO filler showed better biodegradability than PLLA and PCL fillers. In the hairless mouse photoaging model, there was a statistically significant decrease in skin surface roughness after PDO filler injection.
Our data suggest that newly developed collagen stimulating PDO filler might be a safe and effective option for correction of volume loss and rejuvenation of photoaging skin.
越来越多的填充物被用于增加体积损失和放松面部皱纹。胶原刺激剂是最新一代的真皮填充物,可以诱导新的胶原蛋白生成。为了研究新型聚二氧杂环已酮(PDO)填充物与聚左旋乳酸(PLLA)和聚己内酯(PCL)填充物相比的生物物理特性、安全性和疗效。
进行体外检测,测量颗粒的形态和填充物的流变特性。总共 24 只雌性无毛小鼠(SKH1-Hr)被随机分为三组,分别注射 PDO、PLLA 或 PCL 填充物。在注射后 0、3 天和 1、4、8、12 周使用 folliscope 和 PRIMOS 评估填充物的耐久性。为了确定生物相容性和新胶原蛋白生成,在注射后 1、4、8 和 12 周进行组织学评估。还通过 PRIMOS 在无毛鼠光老化模型中评估了疗效,根据皮肤表面粗糙度变化进行评估。
在颗粒形态测试中,PDO 微球表面不规则,呈球形且大小均匀。PDO 填充物表现出与其他胶原刺激剂相似的新胶原蛋白生成和炎症反应。PDO 填充物的生物降解性优于 PLLA 和 PCL 填充物。在无毛鼠光老化模型中,注射 PDO 填充物后皮肤表面粗糙度有统计学意义的下降。
我们的数据表明,新型胶原刺激 PDO 填充物可能是一种安全有效的治疗体积损失和光老化皮肤年轻化的选择。